“…As already reported, ethanolamine derivatives 14a – 14d have been screened against selected Gram-positive and Gram-negative bacteria, including Escherichia faecalis , E. coli , Pseudomonas aeruginosa , Staphylococcus aureus , S. agalactiae , and S. epidermidis , and showed promising antibacterial activity with a minimum inhibitory concentration (MIC) as low as 6.3 μM in the best cases ( 14a and 14d ) ( Scheme 6 ). 32 It was therefore very disappointing when all of the remaining seven analogues were totally inactive (MIC > 100 μM). More compounds have to be prepared and tested before the reason for this difference can be elucidated, but four noteworthy trends have been observed.…”